Dr. Claire Zhang will lead the downstream bioprocessing group of Advanced BioScience Laboratories, Inc. (ABL), a biomedical contract research and manufacturing organization. Dr. Zhang, who has more than 15 years of industry experience, will direct development and optimization programs for ABL’s commercial and government GMP manufacturing clients.

Before joining ABL, Dr. Zhang was the head of Downstream Development and Manufacturing at Intercell, Inc., working on multiple vaccine platforms including recombinant proteins and virus-like particles. She directed teams carrying out process development, scale-up production, process characterization using Design of Experiments (DOE), and GMP manufacturing for toxicology and Phase I-III production. Prior to her time at Intercell, Dr. Zhang worked for Human Genome Sciences and IBEX Pharmaceuticals.

“I am very pleased to welcome Dr. Zhang to the ABL team,” said Beth Tebeau, ABL’s director of Manufacturing. “Her expertise will be invaluable as we continue to advance our Process Development capabilities to better meet the project requirements for quality and yield that are so critical to the success of early stage clinical manufacturing.”